A comparative non randomized study of narrow-band (NB) (312 ± 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin a and NB-UVB phototherapy in patients with severe psoriasis vulgaris

Piergiacomo Calzavara-Pinton, Giovanni Leone, Marina Venturini, Raffaella Sala, Delia Colombo, Ilaria Lesnoni La Parola, Nathalie Sitzia, Carmela Ferraro, Mauro Picardo

Research output: Contribution to journalArticlepeer-review

Abstract

Sequential therapy may improve the efficacy and safety of single treatments for severe psoriasis. We compared sequential Cyclosporin A and narrow-band UVB phototherapy versus narrow-band UVB phototherapy alone. A group of 30 patients with severe psoriasis received 3 mg/kg/day Cyclosporin A for 4 weeks. Afterwards, Cyclosporin A was rapidly tapered and phototherapy begun. An additional 30 patients received phototherapy alone. Treatments were given until psoriasis cleared or until partial improvement was achieved without further amelioration despite another week of treatment. Both treatments were highly effective and well tolerated but sequential therapy was more effective in lesions of UV-shielded body areas; itching disappeared more quickly. The cumulative narrow-band UVB dosages and number of exposures were lower. No difference was seen at follow-up extended up to 9 months. Sequential therapy was well tolerated and allowed for the reduction of narrow-band UVB dosage and exposures, quick relief of itching and improvement of UV-shielded lesions.

Original languageEnglish
Pages (from-to)470-473
Number of pages4
JournalEuropean Journal of Dermatology
Volume15
Issue number6
Publication statusPublished - Nov 2005

Keywords

  • Cyclosporin A
  • Narrow-band UVB radiation
  • Phototherapy
  • Psoriasis
  • Sequential therapy

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'A comparative non randomized study of narrow-band (NB) (312 ± 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin a and NB-UVB phototherapy in patients with severe psoriasis vulgaris'. Together they form a unique fingerprint.

Cite this